Rep. Gilbert Ray Cisneros, Jr. Sells Shares of Kenvue Inc. (NYSE:KVUE)

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Kenvue Inc. (NYSE:KVUE). In a filing disclosed on September 04th, the Representative disclosed that they had sold between $1,001 and $15,000 in Kenvue stock on July 17th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Mesabi Trust (NYSE:MSB) on 7/31/2026.
• Purchased $1,001 – $15,000 in shares of Praxis Precision Medicines (NASDAQ:PRAX) on 7/30/2026.
• Purchased $15,001 – $50,000 in shares of Alkermes (NASDAQ:ALKS) on 7/30/2026.
• Sold $15,001 – $50,000 in shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 7/30/2026.
• Sold $100,001 – $250,000 in shares of Alibaba Group (NYSE:BABA) on 7/24/2026.
• Sold $1,001 – $15,000 in shares of Adobe (NASDAQ:ADBE) on 7/24/2026.
• Sold $1,001 – $15,000 in shares of Viavi Solutions (NASDAQ:VIAV) on 7/21/2026.
• Purchased $1,001 – $15,000 in shares of SailPoint (NASDAQ:SAIL) on 7/21/2026.
• Purchased $1,001 – $15,000 in shares of Glacier Bancorp (NYSE:GBCI) on 7/21/2026.
• Sold $1,001 – $15,000 in shares of FedEx (NYSE:FDX) on 7/21/2026.

Kenvue Stock Performance

Shares of NYSE:KVUE opened at $18.70 on Tuesday. The firm has a market cap of $35.92 billion, a PE ratio of 21.49, a price-to-earnings-growth ratio of 1.67 and a beta of 0.46. The firm’s 50 day simple moving average is $19.18 and its 200-day simple moving average is $18.26. Kenvue Inc. has a one year low of $14.02 and a one year high of $20.69. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.71 and a current ratio of 1.01.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The firm had revenue of $3.96 billion during the quarter, compared to analysts’ expectations of $3.97 billion. During the same quarter in the previous year, the firm posted $0.29 EPS. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. As a group, equities analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th were paid a $0.21 dividend. The ex-dividend date was Wednesday, August 12th. This represents a $0.84 dividend on an annualized basis and a yield of 4.5%. This is an increase from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s payout ratio is currently 96.55%.

Wall Street Analyst Weigh In

Several brokerages have weighed in on KVUE. Wall Street Zen cut Kenvue from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 15th. Barclays increased their target price on shares of Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Zacks Research lowered shares of Kenvue from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 7th. Finally, UBS Group dropped their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 11th. Three analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $19.27.

Institutional Trading of Kenvue

Several hedge funds have recently modified their holdings of the company. Amundi grew its position in shares of Kenvue by 41.2% in the 2nd quarter. Amundi now owns 18,483,326 shares of the company’s stock worth $353,216,000 after buying an additional 5,392,413 shares during the last quarter. California State Teachers Retirement System lifted its position in Kenvue by 1,695.1% during the second quarter. California State Teachers Retirement System now owns 56,438,843 shares of the company’s stock valued at $1,078,546,000 after acquiring an additional 53,294,807 shares during the last quarter. Readystate Asset Management LP lifted its position in Kenvue by 18.9% during the second quarter. Readystate Asset Management LP now owns 1,257,316 shares of the company’s stock valued at $24,027,000 after acquiring an additional 200,000 shares during the last quarter. Ameritas Advisory Services LLC acquired a new stake in Kenvue in the second quarter valued at approximately $41,000. Finally, Wedmont Private Capital boosted its stake in Kenvue by 25.3% in the second quarter. Wedmont Private Capital now owns 123,879 shares of the company’s stock valued at $2,413,000 after acquiring an additional 25,030 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.